BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21575717)

  • 1. Prospective evaluation of Vitamin K2, Raloxifene and their co-administration in osteoporotic rats.
    Tasci AG; Bilgili H; Altunay H; Gecit MR; Keskin D
    Eur J Pharm Sci; 2011 Jul; 43(4):270-7. PubMed ID: 21575717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomechanical and histological outcome of combined raloxifene-estrogen therapy on skeletal and reproductive tissues.
    Tasci A; Bilgili H; Altunay H; Gecit MR; Keskin D
    Eur J Pharmacol; 2010 Feb; 627(1-3):354-61. PubMed ID: 19903467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats.
    Mawatari T; Miura H; Higaki H; Moro-Oka T; Kurata K; Murakami T; Iwamoto Y
    J Bone Miner Res; 2000 Sep; 15(9):1810-7. PubMed ID: 10977000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vitamin K2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Yeh JK
    Calcif Tissue Int; 2010 Sep; 87(3):254-62. PubMed ID: 20556371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene.
    Stürmer EK; Seidlová-Wuttke D; Sehmisch S; Rack T; Wille J; Frosch KH; Wuttke W; Stürmer KM
    J Bone Miner Res; 2006 Jan; 21(1):89-96. PubMed ID: 16355277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats.
    Du Z; Chen J; Yan F; Xiao Y
    Clin Oral Implants Res; 2009 Feb; 20(2):145-50. PubMed ID: 19077150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    Sato M; Bryant HU; Iversen P; Helterbrand J; Smietana F; Bemis K; Higgs R; Turner CH; Owan I; Takano Y; Burr DB
    J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized rats.
    Asawa Y; Amizuka N; Hara K; Kobayashi M; Aita M; Li M; Kenmotsu S; Oda K; Akiyama Y; Ozawa H
    Bone; 2004 Oct; 35(4):870-80. PubMed ID: 15454094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamin K2 on cortical and cancellous bone mass and hepatic lipids in rats with combined methionine-choline deficiency.
    Iwamoto J; Seki A; Sato Y; Matsumoto H; Takeda T; Yeh JK
    Bone; 2011 May; 48(5):1015-21. PubMed ID: 21352961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Dioscorea septemloba on bone metabolism in ovariectomized rats].
    Xing GS; Lou JS; Wang ZB; Yu SL; Wang Y; Sheng L
    Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1909-13. PubMed ID: 18051905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
    Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW
    J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
    Black LJ; Sato M; Rowley ER; Magee DE; Bekele A; Williams DC; Cullinan GJ; Bendele R; Kauffman RF; Bensch WR
    J Clin Invest; 1994 Jan; 93(1):63-9. PubMed ID: 8282823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
    Sato M; Kim J; Short LL; Slemenda CW; Bryant HU
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1252-9. PubMed ID: 7891341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anti-osteoporotic agents on the prevention of bone loss in unloaded bone.
    Siu WS; Ko CH; Hung LK; Lau CP; Lau CB; Fung KP; Leung PC
    Mol Med Rep; 2013 Oct; 8(4):1188-94. PubMed ID: 23970373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.